Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02817581
Other study ID # CRE- 2016.236
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2016
Est. completion date December 30, 2017

Study information

Verified date August 2018
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To validate the NEWS and rapid lactate testing for early identification of high risk [triage Category 3 (urgent)] patients in the Emergency Department.

To compare qSOFA and SIRS criteria in patients in the Emergency Department.


Description:

Background:

Sepsis is a potentially life-threatening complication of an infection. Early identification and early intervention are two main elements in improving patient care.

Objectives:

1. To validate the NEWS and rapid lactate testing for early identification of high risk [triage Category 3 (urgent)] patients in the Emergency Department.

2. To compare qSOFA and SIRS criteria in patients in the Emergency Department.

Study design:

This is a prospective, cohort study. Patients aged 18 or above presenting to the ED triaged as Category 3 (urgent) will be recruited. The required data for calculating NEWS will be collected at triage and triage lactate level will be measured by point-of-care analyzer.

Outcomes:

The primary outcome is referral for intensive care unit (ICU) admission during the patient's ED stay. The secondary outcomes are length of stay in hospital (LOS), hospital admission, admission to ICU, length of ICU-free admission (defined as days alive outside the ICU from admission to day 30) 30-day mortality and time to processes-of-care.


Recruitment information / eligibility

Status Completed
Enrollment 1255
Est. completion date December 30, 2017
Est. primary completion date June 30, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Aged 18 years or above who are triage category 3 in emergency department

- Presenting to emergency department between 9am and 4pm, Monday to Friday

Exclusion Criteria:

- Aged below 18 years

- Pregnant

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Hong Kong Prince of Wales Hospital Sha Tin NT

Sponsors (1)

Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary 30-day mortality 30 days after recruitment
Secondary referral for intensive care unit (ICU) admission 24 hr after recruitment
Secondary length of stay in hospital (LOS) 30 days after recruitment
Secondary hospital admission 30 days after recruitment
Secondary admission to ICU 30 days after recruitment
Secondary length of ICU-free admission 30 days after recruitment
Secondary time to processes-of-care time to lactate measured, time to antibiotics admission, time to blood culture obtained, time to fluid resuscitation, time to vasopressor administration from ED arrival 24 hr after recruitment
See also
  Status Clinical Trial Phase
Completed NCT02694887 - Capillary and Venous Lactate in Emergency Department Patients